Doxin Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 4.67 M
- Company Age 23 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -11.55%
- Profit Growth 43.50%
- Ebitda 67.19%
- Net Worth -2.59%
- Total Assets -17.28%
About Doxin Laboratories
Doxin Laboratories Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 August 2001 and has a history of 23 years and five months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.67 M, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishna Veduruvada and Narendra Veduruvada serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110TG2001PTC034430
- Company No.
034430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2001
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Doxin Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Veduruvada  | Managing Director | 24-Aug-2006 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishna Veduruvada | Director | 01-Feb-2010 | Current |
Financial Performance of Doxin Laboratories.
Doxin Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.55% decrease. The company also saw a substantial improvement in profitability, with a 43.5% increase in profit. The company's net worth dipped by a decrease of 2.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doxin Laboratories?
In 2018, Doxin Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Doxin Laboratories?
Unlock and access historical data on people associated with Doxin Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doxin Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doxin Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
